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Aims of the Vitamin D and Calcium
F o r u m
The Vitamin D and Calcium Forum, an initiati v e
of Osteoporosis Australia (OA) held in partn e r-
s h i p with the Australian and New Zealand Bone
and Mineral Society (ANZBMS), was held in
Melbourne on 28 and 29 July 2005. The Forum
aimed to bring together key stakeholder groups
and experts to specifically develop recommen-
dations regarding optimal vitamin D and calcium
nutrition, as well as approaches to overcoming
barriers to their successful implementation.
Optimal vitamin D and calcium nutrition 
is important in the maintenance of musculo-
skeletal health, but may also have broader effects 
on wellbeing in general. 
It was recognised that vitamin D deficiency is
an emerging public health problem and is 
surprisingly common – even in this country.
Average dietary calcium intake in Australia is
below the recommended daily intake and needs
to be increased, particularly in young women.
In addition, access to low cost and effective 
vitamin D and calcium  supplementation needs
to be made equitable for all Australians, regard-
less of age, gender and socioeconomic situation.
Effective strategies to increase dietary calcium
intake need to be identified.
Changes in bone microarchitecture in osteoporosis
Normal bone. Osteoporotic bone.
Re co m m e n d at i o n s f rom the
Vitamin D and Calcium Fo r u m
This Forum, held in Melbourne on 28 and 29 July 2005, led to the development of important strategies for
achieving improved vitamin D and calcium nutrition in the Australian community.
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Achieving optimal vitamin D
l e v e l s
• Vitamin D deficiency increases the
risk of major illness and adverse health
outcomes, especially osteoporosis,
falls and fracture in the elderly. It is
also associated with other conditions,
including autoimmune diseases
(rheumatoid arthritis, multiple
sclerosis and type 1 diabetes), cardio-
vascular disease and some cancers.
• Major risk factors for vitamin D
deficiency are:
– elderly age and/or being 
institutionalised, house-bound or 
nonambulatory (i.e. having limited
sunlight exposure)
– cognitive impairment
– gastrointestinal disease, especially
with malabsorption
– certain medications (such as 
antiepileptic agents that induce 
liver enzymes)
– limited sunlight exposure or effect
because of skin colour, ethnicity
and/or cultural factors.
• Adequate vitamin D is particularly
important for pregnant women with
risk factors for vitamin D deficiency
because of the long term effects of
fetal deficiency, and for infants of
women at risk (especially if breastfed).
Diagnosing vitamin D deficiency
R e c o m m e n d a t i o n s
• The diagnosis of vitamin D deficiency
involves a single measurement 
of serum 25-hydroxyvitamin D level 
by a reliable assay that measures 
25-hydroxyvitamins D2 and D3 e q u a l l y
(i.e. that derived from ergocalciferol
and cholecalciferol, respectively).
• Exclusion of hypocalcaemia and renal
impairment may be required in the
diagnosis of vitamin D deficiency.
Lifestyle and vitamin D levels
• Attainment of 25-hydroxyvitamin D
values above 50 nmol/L may improve
bone health.
Table. Sun exposure times that result in adequate vitamin D
production without significant risk of skin damage for people
with moderately fair skin*
D e c e m b e r – J a n u a r y July–August  
At 12 noon  
7 minutes
7 minutes  
11 minutes
15 minutes 
16 minutes
19 minutes
25 minutes
29 minutes  
24 minutes
40 minutes 
At 10 am or 2 p m
9 to 12 minutes
9 to 13 minutes
15 to 19 minutes
20 to 28 minutes
26 to 28 minutes
25 to 38 minutes 
32 to 52 minutes
40 to 47 minutes
30 to 47 minutes
49 to 97 minutes
At 10 am or 2 p m†
6 to 7 minutes
5 to 7 minutes 
6 to 7 minutes
5 to 6 minutes
6 to 8 minutes
5 to 7 minutes
6 to 8 minutes 
7 to 9 minutes
6 to 8 minutes
6 to 9 minutes
L o c a t i o n
Australia     
C a i r n s
T o w n s v i l l e
B r i s b a n e
Perth 
Sydney 
Adelaide 
M e l b o u r n e
Hobart 
New Zealand     
A u c k l a n d
Christchurch 
* Exposure to achieve 1/3 minimal erythemal dose (MED) is advised to be before 10 am or after 3 pm. Exposure times for
people with highly pigmented skin are three to six times greater. †1 1 am or 3 pm daylight saving time, respectively.
Adapted from: Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of
Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position
statement. Med J Aust 2005; 182: 281-284.
Modest sunlight exposure on most
days is safe and likely to achieve
vitamin D sufficiency. Exposure
times vary according to latitude and
skin pigmentation.
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R e c o m m e n d a t i o n s
• Consideration of lifestyle change
(increased exposure to sunlight).
Replacement therapy may be required
for some people.
• Exposure of the face, hands and arms
or of the legs to modest amounts of
sunlight to reach one-third of a
minimal erythemal dose (MED) on
most days as part of daily living seems
safe and likely to achieve vitamin D
sufficiency. Exposure should occur
before 10 am or after 3 pm for short
periods of time, the duration of
which depends on latitude and time
of year (see Table). Individuals with
darker skin will require three to six
times longer sun exposure. (One MED
is the amount of sun exposure that
produces a faint redness of the skin.)
• Vitamin D fortification of some foods
would widen dietary options for
individuals to improve their vitamin
D status. However, it is not likely to
be sufficient in itself to treat frank
vitamin D deficiency or to prevent it
in people at high risk.
Vitamin D replacement
• Vitamin D supplementation reduces
the risk of falls by 30% among people
in residential care.
• Vitamin D replacement is relatively
expensive using preparations that
deliver 1000 IU (25 µg) daily.
• Higher dose formulations available in
the USA, Europe, Asia and New
Zealand are not currently available in
Australia.
• Vitamin D3 appears to be more
effective than D2 in raising serum 
25-hydroxyvitamin D and is more
reliably measured in many
commercially available assays.
R e c o m m e n d a t i o n s
• Higher dose preparations that enable
less frequent dosing are likely to be
effective, cheaper and have higher
adherence. A formulation of 50,000 IU
( 1 . 2 5mg) at monthly or more frequent
intervals would have advantages and
could be recommended for individuals
with vitamin D deficiency.
• Most older people in residential care
would benefit from vitamin D
supplementation to reduce falls and
fractures.
• Vitamin D replacement is safe, even in
higher doses up to 600,000 IU (15m g )
per year by intramuscular injection.
• Availability of vitamin D supplements
through Section 3 (restricted) (S3R)
would minimise the risk of individuals
taking a dosage that is higher than
optimal. Waiver of S4 registration costs
is supported.
• In people with severe deficiency,
replacement doses of 5000 to
1 0 , 0 0 0 IU (125 to 250µg) per day are
often required for up to three months
to achieve normal vitamin D levels 
and optimal bone health. A single oral 
dose of 500,000 IU (12.5 mg) can be
given without significant risk of
hypercalcaemia or hypercalciuria.
• Reassessment of vitamin D status
after three months of therapy may be
required by measurement of serum
25-hydroxyvitamin D.
Achieving optimal calcium levels
Dietary intake
• Most older women and men are
unlikely to meet the provisional RDI
(pending approval) of 1300 m g
calcium per day without requiring 
an unrealistically high energy intake
or unbalanced diet. (RDIs for
calcium are expected to be raised in
the near future for males and females
of all ages.)
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• Individuals at highest risk of
inadequate calcium intake are also at
highest risk of osteoporotic fracture
due to other risk factors, including:
– elderly age
– social disadvantage
– gastrointestinal diseases leading to
calcium malabsorption
– corticosteroid use
– sex hormone deficiency.
• The period of rapid skeletal growth in
children is often a time of inadequate
calcium intake.
• Most currently approved treatments
for osteoporosis have been evaluated
in studies of patients with adequate
vitamin D intake and calcium
supplementation.
R e c o m m e n d a t i o n s
• Dairy foods are a good source of
calcium. Low fat options are usually
available and are preferable for some
individuals.
• Availability of a variety of calcium-
fortified foods would improve
options to achieve adequate calcium
intake.
• Although inadequate calcium intake
is likely to be deleterious to bone,
calcium intake beyond the
recommended level is unlikely to
achieve any additional bone health
benefit. Thus, strategies to increase
calcium intake should be focused on
people with the lowest calcium
intakes and/or higher demands 
(e.g. during the pubertal growth
spurt, pregnancy and lactation, after
menopause).
• Adequate calcium intake (obtained
from dietary or supplement sources)
is an essential part of osteoporosis
management.
Calcium supplementation
• The effect of calcium supplement-
a t i o n on bone health is modest, 
as shown by increases in bone 
density and reductions in excessive
bone turnover. The relative risk
reduction for osteoporotic fracture 
is likely not to be more than 10 
to 20%.
• There is no significant difference in
the absorption of calcium from
supplements compared with different
dietary sources (excluding foods rich
in phytate or oxalate, which are
plant-derived compounds that bind
calcium).
R e c o m m e n d a t i o n s
• Adequate calcium intake should be
encouraged in all people, particularly
those at high risk of osteoporotic
fractures.
• It would seem prudent to encourage
a higher calcium intake in the general
population through dietary sources,
or through supplements when this is
not possible.
• Supplements containing calcium in
the form of carbonate require gastric
acidity for optimal absorption and
should therefore be taken with meals.
Supplements containing calcium in
other forms, such as citrate, do not
r e q u i r e gastric acidity.
Other benefits and side effects
• Dairy foods have the advantages of
providing protein and other
micronutrients, in addition to
calcium, that may be important for
general health, particularly in the frail
elderly.
Dairy foods provide protein and
micronutrients, in addition to calcium, 
that may be important for general health,
particulary in the frail elderly.
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• Higher calcium intakes may be
beneficial in preventing colonic cancer
and hypertension, and in improving
lipid profiles.
• There is no evidence of renal calculus
disease or other major side effects,
apart from some constipation, from
calcium supplementation.
• Calcium supplementation does not
have major effects on the absorption
of other micronutrients.
Barriers to adequate calcium
n u t r i t i o n
• Improved dietary calcium intake 
can be limited by calcium-rich food
choices with respect to total energy
intake, especially in the elderly.
• Adherence to calcium supplement-
ation is poor, possibly related to
individuals suffering from digestive
problems or constipation, and the
cost of products.
R e c o m m e n d a t i o n s
• Availability of a variety of calcium-
fortified foods at modest cost is
supported by OA and the ANZBMS.
• Increasing cost from any restriction
of PBS availability is likely to lead to
reductions in the use of calcium
supplements, even as recommended.
• Availability of calcium supplements
providing 500 to 1000 mg/day 
at a modest cost is supported. MT
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Vitamin D and Calcium Forum: topics and speakers
P h y s i o l o g y
Calcium and vitamin D physiology – Associate Professor Rebecca Mason
Calcium at all life stages
Pregnancy and lactation – Dr G. Neil Kent
Children and adolescents – Professor Ailsa Goulding
Middle and older years – Associate Professor Allan Need
Therapeutic applications – Associate Professor Richard Prince
Calcium discussion paper – Professor Ian Reid
Vitamin D at all life stages
Pregnancy and babies – Dr Ruth Morley
Children and adolescents – Professor Graeme Jones
Vitamin D deficiency: groups at risk and replacement – 
Associate Professor Terry Diamond
Falls and falls prevention – Professor John Wark
Primary and secondary fracture prevention – Professor Philip Sambrook
Sunlight, vitamin D and sun damage – Dr Peter Foley
Vitamin D discussion paper – Dr Julie Pasco
Related issues
Calcium and vitamin D regulatory and affordability issues – 
Professor Geoff Nicholson
Myths, minerals and RDIs – Associate Professor Caryl Nowson
Malabsorption and lactose intolerance – Dr Bob Anderson
Further reading
Spinal osteoporotic fractures.
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